# National Medical Research Radiological Centre of the Ministry of Health of Russia: Phase 1 study in Pancreatic Cancer Non-resectable (12 participants)

**Score:** 45/100

| Field | Value |
|---|---|
| Sponsor | National Medical Research Radiological Centre of the Ministry of Health of Russia |
| Sponsor type | Academic and hospital |
| Study | A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer |
| NCT ID | NCT07898683 |
| Phase | Phase 1 |
| Status | recruiting |
| Conditions | Pancreatic Cancer Non-resectable |
| Intervention types | other |
| Target enrollment | 12 |
| Site countries | Russia |
| Posted | 2026-10-27 |
| Planned start | 2025-02-11 |
| Event | Newly registered study |
| Event date | 2026-10-27 |

## Why this score
- Posted in the last two weeks.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07898683). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.